Deal watch: Celgene acquires Gloucester pharmaceuticals, gaining approved HDAC inhibitor.
- Published in:
- 2010
- Publication type:
- journal article
Works matching DE "GLOUCESTER Pharmaceuticals Inc."
Results: 2
1
2
Systemic therapy approved to treat cutaneous lymphoma.
- Published in:
- American Journal of Health-System Pharmacy, 2009, v. 66, n. 24, p. 2150, doi. 10.2146/news090092
- By:
- Publication type:
- Article